33 GENES FOUND

? »

Limit search: Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

Page of 1

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GALNT8Polypeptide N-acetylgalactosaminyltransferase 8Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Voltage-gated ion channels
Tissue enhanced
KCNA1Potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNA10Potassium voltage-gated channel, shaker-related subfamily, member 10FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNA2Potassium voltage-gated channel, shaker-related subfamily, member 2FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNA3Potassium voltage-gated channel, shaker-related subfamily, member 3FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNA4Potassium voltage-gated channel, shaker-related subfamily, member 4FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNA5Potassium voltage-gated channel, shaker-related subfamily, member 5Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNA6Potassium voltage-gated channel, shaker-related subfamily, member 6FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNB1Potassium voltage-gated channel, Shab-related subfamily, member 1FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNC1Potassium voltage-gated channel, Shaw-related subfamily, member 1FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNC2Potassium voltage-gated channel, Shaw-related subfamily, member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNC3Potassium voltage-gated channel, Shaw-related subfamily, member 3Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNC4Potassium voltage-gated channel, Shaw-related subfamily, member 4Predicted membrane proteins
Voltage-gated ion channels
Mixed
KCND1Potassium voltage-gated channel, Shal-related subfamily, member 1FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Mixed
KCND2Potassium voltage-gated channel, Shal-related subfamily, member 2FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND3Potassium voltage-gated channel, Shal-related subfamily, member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNF1Potassium voltage-gated channel, subfamily F, member 1Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNG1Potassium voltage-gated channel, subfamily G, member 1Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNG2Potassium voltage-gated channel, subfamily G, member 2Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNG4Potassium voltage-gated channel, subfamily G, member 4Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNH1Potassium voltage-gated channel, subfamily H (eag-related), member 1Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNH2Potassium voltage-gated channel, subfamily H (eag-related), member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNH3Potassium voltage-gated channel, subfamily H (eag-related), member 3Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNH5Potassium voltage-gated channel, subfamily H (eag-related), member 5Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNH6Potassium voltage-gated channel, subfamily H (eag-related), member 6Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNH7Potassium voltage-gated channel, subfamily H (eag-related), member 7Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNQ1Potassium voltage-gated channel, KQT-like subfamily, member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ2Potassium voltage-gated channel, KQT-like subfamily, member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNQ4Potassium voltage-gated channel, KQT-like subfamily, member 4Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNQ5Potassium voltage-gated channel, KQT-like subfamily, member 5Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNS2Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNS3Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNV2Potassium channel, subfamily V, member 2Disease related genes
Potential drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched

Page of 1